ProteoNic BV, a leading provider of premium vector technology for biopharmaceutical and viral vector production, today announced that its proprietary 2G UNic(R) technology has been licensed by Ginkgo ...
ProteoNic BV, a leading provider of premium vector technology for biopharmaceutical and viral vector production, today announced that its proprietary 2G UNic® technology has been licensed by Ginkgo ...
Integrated analytical workflows are transforming cell line development by combining faster screening and streamlined decision-making.
Diabetes goes beyond just glucose control, and recent advancements in research are enhancing drug development for the disease.
A new artificial intelligence model could help design antibodies that better protect the body against viruses and disease.
African Swine Fever Virus, ASFV, Viral Entry, Host Cell Invasion, CD163, Siglec-1, Macropinocytosis, Endosomal Escape, Immune Evasion, Signaling Pathways Share and Cite: Marcelino, K.B. and Fang, G.J.
Morning Overview on MSN
Antibody injections could replace slow IV drips for many treatments
For patients who rely on monoclonal antibodies and other biologic drugs, treatment often means hours tethered to an IV pole ...
In 1901, Paul Ehrlich conducted one of the landmark experiments in immunology. While studying the immune response in goats using blood from other animals, ...
The study presents convincing quantitative evidence, supported by appropriate negative controls, for the presence of low-abundance glycine receptors (GlyRs) within inhibitory synapses in telencephalic ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback